BioPharma-Reporter.comLonza's stem cell production insight a boon to innovation and businessBioPharma-Reporter.comSo when Swiss-based contract manufacturing organisation (CMO) Lonza published a paper in the Stem Cell Report Journal last week giving industry a comprehensive insight into the cGMP manufacture of human induced pluripotent stem cells (IPSCs), we
http://blog.zandcell.com/lonzas-stem-cell-production-insight-a-boon-to-innovation-and-business-biopharma-reporter-com/
Inga kommentarer:
Skicka en kommentar